Skip to main content

Table 2 BK viruria and/or viremia in all enrolled patients a

From: BK viruria and viremia in children with systemic lupus erythematosus

Patient

At enrollment

3 months

6 months

9 months

12 months

 

Urine

Blood

Urine

Blood

Urine

Blood

Urine

Blood

Urine

Blood

1

Negative

Negative

Negative

Negative

Negative

Positive

15.6

Negative

Negative

n/a

n/a

2

Negative

Negative

Negative

Negative

Negative

Negative

n/a

Negative

n/a

Negative

3

Negative

Negative

Negative

Negative

n/a

Positive

30.9

Negative

Negative

Negative

Negative

4

Negative

Negative

Negative

Negative

Positive

0.03

Positive

2.65

Negative

Negative

Negative

Negative

b 5

Negative

Negative

Negative

Negative

Positive

1.04×10 4

Positive

0.68

Positive

1.86×10 4

Negative

Positive

1.76×10 3

Negative

6

Negative

Negative

Positive

527

Negative

Negative

Positive

4.5

n/a

n/a

Negative

Negative

7

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

8

Negative

Negative

Positive

1.60

Negative

Negative

Negative

n/a

n/a

Negative

Negative

b 9

Negative

Positive

1.5x10 6

Negative

Negative

Negative

Positive

4.3

Negative

Negative

Negative

Negative

10

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

11

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

b 12

Negative

Negative

n/a

Negative

n/a

n/a

n/a

n/a

n/a

n/a

b 13

Negative

Negative

Positive

563

n/a

Negative

Negative

n/a

n/a

n/a

n/a

b 14

Negative

Negative

Negative

Negative

Negative

Negative

n/a

n/a

n/a

n/a

c 15

Negative

Negative

n/a

n/a

n/a

n/a

Negative

Negative

n/a

n/a

16

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

Negative

Negative

17

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

18

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

b 19

Negative

Negative

Negative

Negative

Negative

Negative

n/a

n/a

Negative

Negative

20

Negative

Negative

Negative

n/a

Negative

Negative

Negative

n/a

n/a

n/a

21

Negative

Negative

n/a

n/a

Negative

Negative

n/a

n/a

n/a

n/a

22

Negative

Negative

Negative

Positive

26.5

Negative

Negative

Negative

Negative

n/a

n/a

b 23

Negative

Negative

Positive

2.47

Positive

2.84

n/a

n/a

n/a

n/a

Negative

Negative

24

Negative

Negative

Negative

Negative

Negative

Negative

n/a

n/a

n/a

n/a

25

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

c 26

Positive

0.07

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

c 27

Negative

Positive

33.5

Negative

n/a

n/a

n/a

n/a

n/a

n/a

n/a

28

Negative

Negative

Negative

Negative

Negative

Negative

n/a

n/a

n/a

n/a

29

Negative

Negative

n/a

n/a

n/a

n/a

Negative

Negative

n/a

n/a

30

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

31

Negative

Negative

Negative

n/a

n/a

n/a

Negative

Negative

n/a

n/a

32

Negative

Negative

Negative

Negative

n/a

n/a

n/a

n/a

n/a

n/a

Positive

BKV/Total Samples

(%)

1/32

(3.1%)

2/32

(6.2%)

4/22

(18.1%)

2/19

(10.5%)

2/18

(11.1%)

6/19

(31.5%)

1/13

(7.6%)

0/13

(0%)

1/12

(8.3%)

0/13

(0%)

  1. a BKV copies/ml
  2. b MCTD
  3. c Overlap syndrome, n/a—not available
  4. Bold italic indicates positive tests